Search details
1.
Fertility discussions in young adult stage III colorectal cancer population: a single-center institution experience.
Support Care Cancer
; 29(12): 7351-7354, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34050401
2.
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
Br J Cancer
; 121(6): 505-510, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31406299
3.
Physician interpretation of genomic test results and treatment selection.
Cancer
; 124(5): 966-972, 2018 03 01.
Article
in English
| MEDLINE | ID: mdl-29165790
4.
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
Invest New Drugs
; 33(4): 911-20, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25990659
5.
A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan.
Support Care Cancer
; 23(3): 661-70, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25160493
6.
Phase I Trial of SPECT-Guided Liver-Directed Radiotherapy for Patients with Low Functional Liver Volume.
JNCI Cancer Spectr
; 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38730548
7.
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
JAMA Netw Open
; 7(2): e240260, 2024 Feb 05.
Article
in English
| MEDLINE | ID: mdl-38416491
8.
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.
Cancer Chemother Pharmacol
; 92(2): 107-118, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37314501
9.
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.
JCO Precis Oncol
; 7: e2300228, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37824798
10.
Survival improvement for patients with metastatic colorectal cancer over twenty years.
NPJ Precis Oncol
; 7(1): 16, 2023 Feb 13.
Article
in English
| MEDLINE | ID: mdl-36781990
11.
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Cancer Res Commun
; 3(12): 2510-2517, 2023 12 11.
Article
in English
| MEDLINE | ID: mdl-38085001
12.
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
medRxiv
; 2023 Sep 11.
Article
in English
| MEDLINE | ID: mdl-37745596
13.
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Cancer Immunol Res
; 11(7): 925-945, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37172100
14.
Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer.
J Gastrointest Oncol
; 13(2): 647-656, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35557581
15.
Colorectal cancer during pregnancy or postpartum: Case series and literature review.
Obstet Med
; 15(2): 118-124, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35845232
16.
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
J Immunother Cancer
; 10(8)2022 08.
Article
in English
| MEDLINE | ID: mdl-36007963
17.
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer.
JAMA Netw Open
; 5(10): e2236357, 2022 10 03.
Article
in English
| MEDLINE | ID: mdl-36239938
18.
Bintrafusp alfa, an anti-PD-L1:TGF-ß trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer.
Cancer Res Commun
; 2(9): 979-986, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36382087
19.
Comprehensive Clinical and Molecular Characterization of KRAS G12C-Mutant Colorectal Cancer.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34250391
20.
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Clin Colorectal Cancer
; 20(2): 137-147.e1, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33229221